Resultados: 6

Relatório Anual de Balanço do Sector de Saúde 2021
Annual Health Sector Balance Sheet Report 2021Annual Health Sector Balance Sheet Report 2021

O presente relatório apresenta o balanço anual do sector 2021, cuja finalidade é avaliar o desempenho do sector da saúde, relativamente aos objectivos, metas e planos propostos, assim como analisar e identificar lacunas e desafios para orientar o processo de planificação estratégica e operacional ...

Tuberculose nasal: apresentação de um caso clínico
Nasal tuberculosis: presentation of a clinical case

A Tuberculose (TB) é uma das patologias mais antigas da humanidade e constitui um problema importante de saúde pública mundial1. A tuberculose pulmonar é a forma mais comum, entre tanto, pode afectar diferentes órgãos., . A tuberculose extra-pulmonar afecta sobretudo os seguintes órgãos e/ou regi...

Tuberculosis on the rise in southern Mozambique (1997-2012)

Eur. respir. j; 49 (3), 2017
Tuberculosis (TB) remains an important public health concern and a leading cause of disease and death worldwide. Mozambique is one of the few high-burden countries where incidence rates have not improved in recent years. The estimated TB incidence rate in 2014 was 552 cases per 100 000 population and t...

High tuberculosis burden among people living with HIV in southern Mozambique

Eur. respir. j; 45 (2), 2015
Tuberculosis (TB) remains an important public health concern, and a leading cause of disease and death worldwide. Mozambique is one of the few high TB burden countries where TB figures have not improved in recent years, with an estimated TB incidence in 2013 of 552 cases per 100 000 population [1]. With ...

Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship

J. antimicrob. chemother; 70 (1), 2015
Objectives: We describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12146/12214-CARINEMO trial. Methods: Participants were randomly selected to receive either nevirapine at 200 mg twice daily...

Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial

Lancet, Infect. dis.; 13 (4), 2013
In countries with a high incidence of HIV and tuberculosis co-infection, nevirapine and efavirenz are widely used as antiretroviral therapy but both interact with antituberculosis drugs. We aimed to compare efficacy and safety of a nevirapine-based antiretroviral therapy (started at full dose) with an ef...